F. M. Perron-Sierra et al. / Tetrahedron Letters 45 (2004) 4163–4166
4165
aluminum complexation by the ketal oxygens, yielding
the desired isomer 9 in 72% yield, after acetylation of the
crude amine. Replacement of the O-silyl by a O-benzyl
gave the orthogonally protected intermediate 10, which
was hydrolyzed to the key diol 11 in 20% overall yield
from mannose. When compound 11 was subjected to
diethoxyacetic acid ethyl ester as in the model study, no
cyclization occurred in the various acidic reaction con-
ditions attempted, compatible with the benzyl group
stability. The transient a-carbethoxy oxonium was rap-
idly trapped by the ethoxy counterion, producing the
corresponding mixed acetal 12. To successfully perform
the cyclization, it was necessary to stabilize the oxonium
intermediate via the appropriate introduction of a sub-
stituent, precursor of a carbethoxy functionality and
allowing charge delocalization, such as a vinyl group.
When diol 11 was combined with an excess of acrolein in
the presence of catalytic butyltintrichloride, the cycli-
zation was performed in excellent yield, giving the
desired isomer 13 as a single product.18 Conventional
functional group manipulation involving osmylation of
the exocyclic olefin, sodium periodate-catalyzed bond
breaking to aldehyde 14, and subsequent silver nitrate
acid backbone, reminiscent of CMP-sialic acid sub-
strate, and/or a sugar-like substituent. Incorporation of
the dioxan sialic acid moiety 4 at the terminus of sialyl-
conjugates as new bisubstrate analogs is underway.
Supplementary material: spectroscopic and physical
characterization data for compound 4 (1H, 13C NMR
spectra, IR, CHN, MH, optical rotation).
Acknowledgements
The authors wish to thank Sabine Plantier for her
skillful technical assistance and Solange Huet for the
preparation of the manuscript. We would like also to
acknowledge the analytical department at the Institut de
Recherches Servier for performing all the spectral
analyses.
References and notes
oxidation afforded the desired carboxylic acid
(Scheme 2).
4
€
1. (a) Reutter, R.; Kottgen, E. K.; Bauer, C.; Gerok, W.;
Biological, J. Significance of Sialic Acids. In Sialic Acids
Chemistry, metabolsm and Function, Cell Biology mono-
graphs; Schauer, R., Ed.; Springer: Wien, 1982; Vol. 10, pp
263–305; (b) Varki, A. Glycobiology 1993, 3, 97–130; (c)
Hodgson, J. Biotechnology 1991, 9, 609–613; (d) Neel, D.;
Aubery, M.; Derappe, C. Medicine/Sciences 1992, 8, 233–
238.
Its conformation was assessed by NMR,19a with nuclear
Overhauser effects (NOE) between 1,3-diaxial hydro-
gens, and an order of magnitude of 9–10 Hz of the
transdiaxial coupling constants.18 Moreover NMR
titration confirmed an experimental pKa value of 2.8,
close to that of sialic acid. Indeed, molecular modeling
(MOPAC calculations),20 comforting these data,
showed superimposition of compound 4 with sialic acid
(Fig. 3).
2. (a) Schauer, R. Trends Biol. Sci. 1985, 357–360; (b) Kelm,
S.; Schauer, R.; Croker, P. Glycoconjugate J. 1996, 13,
913–926; (c) Schauer, R. Sialic Acids Regulate Cellular
and Molecular Recognition. In Carbohydrates; Ogura, H.,
Hasegawa, A., Suami, T., Eds.; VCH: Weinheim–New
York, 1992; pp 340–401.
3. Musser, J. H.; Anderson, M. B.; Levy, D. E. Curr. Pharm.
Des. 1995, 1, 221–232.
4. (a) Fukuda, M. Cancer Res. 1996, 56, 2237–2244; (b)
Brooks, P. C. Cancer Metastasis Rev. 1996, 15, 187–194;
(c) Brocke, C.; Kunz, H. Bioorg. Med. Chem. 2002, 10,
3085–3112.
As a preliminary evaluation of the enzymatic activity,
compound 4 was assayed on purified a-2,6-sialyltrans-
ferase.21 However, as with sialic acid, no inhibition was
found up to 1 mM. Indeed, the only active inhibitors
described are the bisubstrate transition state mimics6;7
containing either a bisacid functionality on the sialic
5. (a) Burmeister, W.-P.; Daniels, R. S.; Dayan, S.; Gagnon,
J.; Cusack, S.; Ruigrok, R. W. H. Virology 1991, 180, 266–
272; (b) von Itzstein, M.; Wu, W.-Y.; Kok, G. B.; Pegg,
M. S.; Dyason, J. C.; Jin, B.; Phan, T. V.; Smythe, M. L.;
White, H. F.; Oliver, S. W.; Colman, P. M.; Varghese, J.
N.; Ryan, D. M.; Woods, J. M.; Bethell, R. C.; Hotham,
V. J.; Cameron, J. M.; Penn, C. R. Nature 1993, 363, 418–
423.
6. (a) Wong, C.-H.; Moris-Varas, F.; Hung, S.-C.; Marron,
T. G.; Lin, C.-C.; Gong, K. W.; Weitz-Schmidt, G. J. Am.
Chem. Soc. 1997, 119, 8152–8158; (b) Lin, C.-C.; Moris-
Varas, F.; Weitz-Schmidt, G.; Wong, C.-H. Bioorg. Med.
Chem. 1999, 425–433; (c) Kaila, N.; Thomas, B. E. Med.
Res. Rev. 2002, 22(6), 566–601.
€
7. (a) Amann, F.; Schaub, C.; Muller, B.; Schmidt, R. R.
Chem. Eur. J. 1998, 4, 1106–1115; (b) Schroder, P. N.;
€
Giannis, A. Angew. Chem., Int. Ed. 1999, 38, 1379–1380;
(c) Whalen, L. J.; McEvoy, K. A.; Halcomb, R. L. Bioorg.
Med. Chem. Lett. 2003, 13, 301–304; (d) Wang, X.; Niu,
Y.; Cao, X.; Zhang, L.; Zhang, L.-H.; Ye, X.-S. Bioorg.
Med. Chem. 2003, 11, 4217–4224; (e) Wang, X.; Zhang,
L.-H.; Ye, X.-S. Med. Res. Rev. 2003, 23, 32–47.
Figure 3. Comparison of sialic acid (green) and [1,3] dioxane analog 4
(white).